Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study
Journal of Surgical Oncology, EarlyView.
Source: Journal of Surgical Oncology - Category: Cancer & Oncology Authors: ShinichiKomiyama
,
TsuyokiKugimiya
,
KaneyukiKubushiro Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries | Study